Symbol="APVO"
AssetType="Common Stock"
Name="Aptevo Therapeutics Inc"
Description="Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company is headquartered in Seattle, Washington."
CIK="1671584"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2401 4TH AVE., SUITE 1050, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4495400"
EBITDA="-30691000"
PERatio="None"
PEGRatio="0"
BookValue="2.155"
DividendPerShare="0"
DividendYield="0"
EPS="-3.52"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.58"
ReturnOnEquityTTM="-0.972"
RevenueTTM="0"
GrossProfitTTM="3114000"
DilutedEPSTTM="-3.52"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="3.945"
PriceToSalesRatioTTM="1.607"
PriceToBookRatio="0.814"
EVToRevenue="0.122"
EVToEBITDA="-0.0345"
Beta="5.18"
num_52WeekHigh="3.97"
num_52WeekLow="0.367"
num_50DayMovingAverage="1.046"
num_200DayMovingAverage="1.885"
SharesOutstanding="11523700"
DividendDate="2020-03-27"
ExDividendDate="None"
symbol="APVO"
open="0.39"
high="0.40"
low="0.39"
price="0.40"
volume="37468.00"
latest_trading_day="2023-08-25"
previous_close="0.39"
change="0.01"
change_percent="2.5162%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="210164"
Change_recent_avg="-0.02"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.81"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="113"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_negative_thumbnail_id_2="1100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="987"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
